Preparing for China · patient guide

Myeloproliferative neoplasm care: questions to settle before you travel

Before travelling to China for myeloproliferative neoplasm care, settle five things in writing: which MPN you have and how it is currently monitored, whether the purpose is a records-based opinion or hands-on treatment, how your medicines will be supplied and monitored, what the hospital's written plan and quote cover, and what you will do if your condition changes en route. The receiving haematology team decides suitability; an enquiry or records review does not establish treatment access.

Go to the practical guidance ↓
AI illustration: A female doctor in a white coat consulting with a female patient in a blue shirt at a desk with a clipboard and notebook.
AI-generated illustration for care planning; not a photograph of a real patient, clinician or hospital, and not a diagnostic image.
In this guide

Start with the diagnosis, not the destination

Myeloproliferative neoplasms are a group of blood disorders that include polycythaemia vera, essential thrombocythaemia and primary myelofibrosis. They are grouped together because they share features at the level of the bone marrow's blood-producing cells, but they behave differently and are monitored differently. A travel plan that treats "MPN" as one condition will not give a haematologist enough to work with.

The first question to settle is therefore specific: what is your exact diagnosis, and what evidence supports it? Ask your current team for the reports that establish it, including bone-marrow findings where a sample was taken, and any molecular results such as JAK2, CALR or MPL testing. These are the documents a receiving clinician will want before discussing anything else.

The second question is what your current team is actually watching. MPN care often involves tracking blood counts over time, reviewing symptoms such as fatigue, itching, early fullness or night sweats, and watching for vascular events or progression. Ask your haematologist to summarise the trend, not just the latest result, and to state in one or two sentences what would prompt a change in your plan. That summary is often more useful to a new clinician than a thick folder of individual results.

Finally, settle why you are considering China. A records-based opinion, a second look at the diagnosis, a discussion about treatment options, and hands-on ongoing care are different requests with different preparation. Mixing them together in one enquiry tends to produce a vague reply. State the single question you most want answered.

Decide whether you need an opinion or hands-on care

A records-based opinion can be arranged while you remain at home: your records are taken to a relevant hospital specialist, who gives an opinion based on those documents. This is a genuine clinical view, but it is limited by what the file contains, and it does not by itself establish hospital acceptance, treatment availability or fitness to travel. Those remain decisions for the receiving team after they have what they need.

Hands-on care is a different commitment. It raises questions about how long you would stay, who would take over prescribing, how monitoring would be scheduled, and how you would return to your existing team afterwards. Ask the hospital directly how it handles each of these. Do not assume that a first appointment automatically leads to treatment, or that a treatment plan can be completed within a single visit.

For a complex case that crosses specialties, a review involving more than one specialty may be appropriate. The scope and fee for such a review are agreed before it starts. Ask what specialties would be involved and what specific question the review is meant to answer.

It is reasonable to begin with a short summary rather than a complete archive. Our team's free initial case review checks the available diagnosis, records and your main question, identifies missing information and suggests a relevant next step. It is not a diagnosis and does not promise acceptance.

Related treatment reference

Settle medicines, monitoring and what happens between visits

MPN care frequently involves medicines taken over long periods, plus regular blood tests to check response and safety. Before travelling, ask your current haematologist and the receiving team separately about the same practical points, and compare the answers.

Which medicines are you taking, at what dose, and which of them must not be interrupted? Ask for a written list with generic names, since brand names differ between countries. Ask the receiving hospital whether it can supply and monitor those medicines, and what it needs from you before it can answer. Do not change or stop any prescribed medicine on the basis of an article or an enquiry reply; that belongs to the clinicians responsible for your care.

How will monitoring be arranged? Ask how blood tests would be scheduled, who reviews the results, and how findings would be shared with your home team. Ask what the hospital's written plan says about follow-up between appointments, and who you would contact if a result needed attention.

What about travel and clotting risk? MPN can be associated with an increased risk of thrombosis and, in some situations, bleeding. Ask your treating haematologist whether any aspect of your condition affects how you should travel, and follow their advice. This is a clinical judgement about you, not a general rule that can be settled by a travel article.

Carry your medicines in original packaging with a copy of your prescription, and ask your treating team and the relevant authorities about documentation for controlled or restricted products before departure. Customs and prescribing questions belong to those authorities and licensed clinicians, not to a coordination service.

Ask what the written plan and quote actually cover

Cost questions are easier to settle before travel than after. Ask the hospital for a written plan that names the proposed assessments, the treatment or monitoring being considered, and the fee scope. Then ask what that quote does not include. Without that document, a number on its own tells you very little.

Separate three kinds of cost. Hospital charges for consultations, tests, treatment, medicines and rooms are paid to the hospital or relevant provider. Our coordination fees are separate and are not offset against later hospital charges. Travel, accommodation and interpretation are further separate costs. Ask each provider what its own quote covers rather than assuming a single inclusive figure.

For MPN specifically, the relevant items may include repeat blood counts, bone-marrow review, molecular testing, medicine costs and follow-up visits. Ask which of these the hospital expects to provide, which would need to be arranged elsewhere, and how the estimate would change if the plan changed after assessment. A final quote may differ from an initial estimate once the treating team has seen you.

If you want a records-based estimate before travelling, ask what records are needed for it and be clear that it is an estimate, not a fixed price. Our specialist appointment coordination service covers expert matching and appointment registration, with hospital consultation fees charged separately. Treatment coordination is arranged case by case after hospital acceptance, and no standard public fee applies to it.

Prepare the records a haematologist will actually use

A haematologist reviewing an overseas file wants a clear chronology and the source documents behind it. Ask your current team to help you assemble a short summary: diagnosis and date, key test results with dates, treatments tried and responses, current medicines and doses, and the main question you want addressed. Then attach the original reports that support the summary.

Include blood-count trends rather than isolated values, bone-marrow reports, molecular and cytogenetic results, imaging where relevant, and clinic letters that record decisions and their reasons. If something is missing, say so rather than filling the gap with a guess. A receiving clinician can work with an acknowledged gap; a misleading summary is harder to correct.

Ask about language. Reports in English are helpful, but the hospital will tell you what it can work with and whether translation is needed. Do not assume a universal English report or a fixed turnaround. Confirm arrangements with the particular hospital.

Keep the initial contact brief. A short summary by the enquiry form, email or WhatsApp is enough to start; more detailed records can be shared once the next step is clear. Do not send passport numbers, card details or a complete medical archive at first contact.

Agree the safety net before you book

The most important question is often the least discussed: what happens if your condition changes while you are away from home? Ask your current haematologist what symptoms should prompt urgent assessment, and ask the receiving team how a patient with your condition would access urgent care in the city you plan to visit. Write the answers down and keep them with your records.

Ask who would be responsible for your care at each stage: before travel, on arrival, during treatment and after you return. A handover works only when records and responsibility are actually exchanged, so ask what the receiving team will send back to your home clinicians and when. Do not assume that only your original team can assess you; a receiving haematologist can form an independent view, and it is reasonable to ask how that view will be shared.

Be realistic about what a trip can achieve. If your clinicians advise that travel should wait, or that a change in your condition needs assessment first, that advice takes priority over any appointment. Urgent or worsening symptoms need local medical care, not a planned journey.

Once these points are settled, the next step is small: send a brief summary of the diagnosis, current monitoring and your single main question through the enquiry form, email or WhatsApp. An initial enquiry is free and does not require buying a proxy consultation. The hospital decides suitability, and any appointment, estimate or plan is confirmed in writing afterwards.

Sources & scope of this guide

References and official service information relevant to this guide.

  1. Related treatment reference
  2. Myeloproliferative Neoplasms Treatment - NCI

This is general planning information and has not been individually reviewed by a doctor. Medical decisions and personal treatment advice come from your treating clinicians.